Claims for Patent: 8,993,303
✉ Email this page to a colleague
Summary for Patent: 8,993,303
Title: | Genetically engineered cyanobacteria |
Abstract: | The disclosed embodiments provide cyanobacteria spp. that have been genetically engineered to have increased production of carbon-based products of interest. These genetically engineered hosts efficiently convert carbon dioxide and light into carbon-based products of interest such as long chained hydrocarbons. Several constructs containing polynucleotides encoding enzymes active in the metabolic pathways of cyanobacteria are disclosed. In many instances, the cyanobacteria strains have been further genetically modified to optimize production of the carbon-based products of interest. The optimization includes both up-regulation and down-regulation of particular genes. |
Inventor(s): | Zhou; Ruanbao (Brookings, SD), Gibbons; William (Brookings, SD) |
Assignee: | South Dakota State University (Brookings, SD) |
Application Number: | 13/405,208 |
Patent Claims: | 1. A composition comprising an Anabaena spp. genetically engineered with at least one recombinant polynucleotide expression construct, wherein the at least one recombinant
polynucleotide expression construct comprises a nucleotide sequence encoding at least one enzyme, wherein the at least one enzyme increases production of a carbon based product of interest by the genetically engineered Anabaena spp. following expression
of the polynucleotide expression construct, wherein said Anabaena spp. is ethanol producing Anabaena sp. PCC7120 (pZR672) strain deposited under ATCC accession number PTA-12833 or is linalool producing Anabaena sp. PCC7120 (pZR808) strain deposited
under ATCC accession number PTA-12832.
2. The composition of claim 1 wherein the Anabaena spp. is Anabaena PCC7120 (pZR672) strain deposited under ATCC accession number PTA-12833. 3. The composition of claim 1, wherein the Anabaena spp. is linalool producing Anabaena sp. PCC7120 (pZR808) strain deposited under ATCC accession number PTA-12832. 4. The composition of claim 1 wherein the Anabaena spp. has an up-regulated 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway. 5. The composition of claim 4 wherein the up-regulated MEP pathway is up-regulated by expressing at least one gene responsible for control of the MEP pathway in the Anabaena spp. 6. The composition of claim 1 wherein the at least one recombinant polynucleotide expression construct further comprises a nucleotide sequence encoding ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCo). 7. The composition of claim 6 wherein the at least one recombinant polynucleotide expression construct comprising a nucleotide sequence encoding RuBisCo, further comprises a nucleotide sequence encoding RuBisCo activase. 8. The composition of claim 1 wherein the carbon based product of interest is ethanol. 9. The composition of claim 1 wherein the Anabaena spp. is combined with a photoautotrophic liquid media, and optionally, wherein said media contains no combined nitrogen. 10. The composition of claim 1 wherein the carbon based product of interest is linalool (C.sub.10H.sub.18O). |
Details for Patent 8,993,303
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | ACTIVASE | alteplase | For Injection | 103172 | 11/13/1987 | ⤷ Try a Trial | 2031-02-24 |
Genentech, Inc. | CATHFLO ACTIVASE | alteplase | For Injection | 103172 | 09/04/2001 | ⤷ Try a Trial | 2031-02-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.